Skip to content

Comparative study between Amaltas Kashaya and vidangadi lepa and Navakashaya and vidangadi lepa in participants suffering from Vicharchika.

Effect of Amaltas Kashaya and Vidangadi lepa in comparison with Navakashaya and Vidangadi lepa in the management of Vicharchika W.S.R. to Eczema. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088396
Enrollment
60
Registered
2025-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L208- Other atopic dermatitis

Interventions

None listed

Sponsors

Dr. Dilpreet kaur juneja
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients of age group between 20-50 years. 2)Subjects suffering with vicharchika up to 3 year of chronicity. 3)patients having signs and symptoms of vicharchika (eczema) described in classical ayurvedic text as well as in modern medical literature.

Exclusion criteria

Exclusion criteria: 1)Patients of vicharchika having secondary infections. 2)Patients suffering with diabetes mellitus. 3)Pregnant and lactating mothers. 4)Patients with impaired cardiac, renal and hepatic functions, leprosy, psoriasis, pulmonary tuberculosis

Design outcomes

Primary

MeasureTime frame
To compare the clinical effect of Amaltas Kashaya with Vidanagadi Lepa and Navakashaya and Vidangadi Lepa in Vicharchika w.s.r. to Eczema.Timepoint: At the end of 30 days.

Secondary

MeasureTime frame
To provide better drug of choice for Vicharchika w.s.r. to Eczema.Timepoint: At the end of 30 days.

Countries

India

Contacts

Public ContactDR Dilpreet Kaur Juneja

Shri Ayurved Mahavidyalaya Nagpur

dr.dachewar@gmail.com982220631

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026